Work

Genetic inference of immune responsiveness of melanoma cancer patients to TIL therapy

Year: 2013

Type: article

Abstract: Meeting abstracts Adoptive cell transfer therapy (ACT) holds a highly promising treatment for metastatic melanoma patients. ACT involves the ex vivo expansion of autologous antitumor reactive tumor infiltrating lymphocytes and their reinfusion into lymphodepleted patients, accompanied by IL-2

Source: Journal for ImmunoTherapy of Cancer

DOI: 10.1186/2051-1426-1-s1-p63

Authors: Michele Sommariva, Foo Cheung, Jinguo Chen, Rongye Shi, Ling Zhang, Richard Morgan, Davide Bedognetti, Valeria De Giorgi, Maria L Ascierto, Steven A Rosenberg, Francesco M Marincola, Ena Wang

Institutions: National Institutes of Health, University of Milan, National Institutes of Health Clinical Center, National Cancer Institute, Sidra Medical and Research Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,490

OpenAlex ID: W2074788814

FWCI:

Cites:

Cited by:

Related to: 10